Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

OP45 Anti-DCC Mouse mAb (AF5)

Anti-DCC Mouse mAb (AF5) MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.

Synonyms: Anti-Deleted Colorectal Carcinoma

OP45
  
Purchase on Sigma-Aldrich

Áttekintés

Replacement Information

Kulcsspecifikációk táblázata

Species ReactivityHostAntibody Type
HMMonoclonal Antibody
Description
Overview

This product has been discontinued.



Recognizes the ~190 kDa DCC protein in IMR32 cells.
Catalogue NumberOP45
Brand Family Calbiochem®
SynonymsAnti-Deleted Colorectal Carcinoma
References
ReferencesDunlop, M.G. 1992. Cancer Biol. 3, 131.
Goyette, M.C., et al. 1992. Mol. Cell. Biol. 12, 1387.
Hohne, M.W., et al. 1992. Cancer Res. 52, 2616.
Huang, Y., et al. 1992. Cancer Res. 52, 6525.
Kikuchi-Yanoshita, R., et al. 1992. Cancer Res. 52, 3801.
Tanaka, K., et al. 1991. Nature 349, 340.
Fearon, E.R., et al. 1990. Science 247, 49.
Fearon, E.R., and Vogelstein, B. 1990. Cell 61, 759.
Miyaki, M., et al. 1990. Cancer Res. 50, 7166.
Vogelstein, B., et al. 1989. Science 244, 207.
Product Information
FormLiquid
FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
Negative controlSW480 cells
Positive controlIMR32 cells
Preservative≤0.1% sodium azide
Quality LevelMQ100
Applications
Key Applications Immunoblotting (Western Blotting)
Immunofluorescence
Immunoprecipitation
Application NotesImmunoblotting (1-5 µg/ml)
Immunofluorescence (1-5 µg/ml)
Immunoprecipitation (1-2 µg/sample)
Application CommentsIMMUNOBLOTTING PROCEDURE

Anti-DCC (Ab-1) can be used to immunoblot proteins previously separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretically transferred onto nitrocellulose membranes. The proteins are reacted with the monoclonal antibody and visualized using an HRP conjugated goat anti-mouse antibody and chemiluminescent detection.

Materials:

1. Equipment

• Electrophoresis apparatus
• Rocker platform

2. Solutions and Reagents

• Anti-DCC (Ab-1), Cat. No. OP45
• Anti-mouse IgG conjugated to horseradish peroxidase
• Chemiluminescent detection reagents
• 1x Laemmli Sample Buffer: 60 mM Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT, 0.001% Bromophenol Blue
• 7.5% polyacrylamide gel
• Tris-buffered saline (TBS) pH 7.6: 20 mM Tris base, 137 mM NaCl, pH to 7.6 with HCl
• TBS/0.1% Tween®-20 detergent (TBST)
• 10% Non-fat Dry Milk in TBST
• 5% Non-fat Dry Milk in TBST

Procedure:

1) Lyse cells in 1x Laemmli Sample Buffer. For adherent cells, lyse a 10 cm plate in 2 ml of sample buffer added directly to cells on the plate. Final protein concentration is approximately 1 mg/ml.
2) Electrophorese 50-100 µg of total lysate protein on SDS/PAGE (7.5% polyacrylamide).
3) Transfer the proteins onto a nitrocellulose membrane using an electroblotting apparatus.
4) Block the membrane for 1 h in 10% non-fat dry milk in TBSTat room temperature with rocking. Use about 1 ml per cm2 of membrane.
5) Incubate the membrane with 1 µg/ml of Anti-DCC (Ab-1) in 5% non-fat dry milk in TBST for 2 h at room temperature with rocking.
6) Wash the membrane 3 times, 10 min each, in TBST at room temperature with rocking
7) Incubate the membrane with 100 ng/ml of HRP conjugated goat anti-mouse IgG antibody in 5% non-fat dry milk in TBST at room temperature for 1 h.
8) Wash the membrane 6 times, 10 min each, in TBST at room temperature with rocking.
9) Develop the membrane using chemiluminescent detection reagents according to manufacturers instructions.
10) Expose the membrane to film for 10 min. Adjust exposure times (from 30 s to 24 h) as necessary.
Biological Information
Immunogenthe extracellular domain of human DCC
ImmunogenHuman
CloneAF5
HostMouse
IsotypeIgG₁
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Concentration Label Please refer to vial label for lot-specific concentration
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Blue Ice Only
Toxicity Standard Handling
Storage +2°C to +8°C
Do not freeze Yes
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
OP45 0

Documentation

Anti-DCC Mouse mAb (AF5) MSDS

Title

Safety Data Sheet (SDS) 

Anti-DCC Mouse mAb (AF5) Certificates of Analysis

TitleLot Number
OP45

References

Hivatkozások áttekintése
Dunlop, M.G. 1992. Cancer Biol. 3, 131.
Goyette, M.C., et al. 1992. Mol. Cell. Biol. 12, 1387.
Hohne, M.W., et al. 1992. Cancer Res. 52, 2616.
Huang, Y., et al. 1992. Cancer Res. 52, 6525.
Kikuchi-Yanoshita, R., et al. 1992. Cancer Res. 52, 3801.
Tanaka, K., et al. 1991. Nature 349, 340.
Fearon, E.R., et al. 1990. Science 247, 49.
Fearon, E.R., and Vogelstein, B. 1990. Cell 61, 759.
Miyaki, M., et al. 1990. Cancer Res. 50, 7166.
Vogelstein, B., et al. 1989. Science 244, 207.
Data Sheet

Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

Revision03-October-2007 RFH
SynonymsAnti-Deleted Colorectal Carcinoma
ApplicationImmunoblotting (1-5 µg/ml)
Immunofluorescence (1-5 µg/ml)
Immunoprecipitation (1-2 µg/sample)
DescriptionPurified mouse monoclonal antibody. Recognizes the ~190 kDa DCC protein.
BackgroundInvasive, metastatic colon cancer arises from pre-existing adenomas in both familial and sporadic cases and is characterized by the presence of multiple chromosomal alterations. In the progression from intramucosal carcinoma to invasive carcinoma, allelic loss on the long arm of chromosome 18 is frequently observed. Recently, a gene on 18q21.3 termed DCC, for deleted in colorectal carcinoma, has been isolated and shown to be deleted or mutated in both sporadic and inherited colon carcinoma whereas normal colonic tissue retained and expressed the gene. Furthermore, loss of DCC expression appears to accompany progression of adenomas to metastatic carcinoma. The inactivation of DCC suggests that it is a tumor suppressor gene. A functional role for DCC as a tumor suppressor gene is indicated by experiments demonstrating that introduction of a normal chromosome 18 into the human colon tumor cell lines COKFu or SW480.7 lacking DCC suppresses tumorigenicity. Analysis of the amino acid sequence deduced from cDNA clones indicates that DCC is a transmembrane glycoprotein consisting of 1447 amino acids with an extracellular domain having extensive similarity to neural cell adhesion molecules (NCAM), a single transmembrane segment, and a unique cytoplasmic domain. The high degree of similarity to NCAMs suggests that DCC is involved in cell-cell interactions essential to the differentiated state of the colonic epithelium. DCC expression has been observed in all tissues examined except liver with the highest level of expression in brain tissue. Alterations in DCC expression have also been observed in pancreatic adenocarcinoma and esophogeal carcinoma. However, DCC mRNA is expressed at very low levels, requiring reverse transcription followed by PCR amplification for unambiguous detection.
HostMouse
Immunogen speciesHuman
Immunogenthe extracellular domain of human DCC
CloneAF5
IsotypeIgG₁
Specieshuman
Positive controlIMR32 cells
Negative controlSW480 cells
FormLiquid
FormulationIn 0.05 M sodium phosphate buffer, 0.2% gelatin.
Concentration Label Please refer to vial label for lot-specific concentration
Preservative≤0.1% sodium azide
CommentsIMMUNOBLOTTING PROCEDURE

Anti-DCC (Ab-1) can be used to immunoblot proteins previously separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrophoretically transferred onto nitrocellulose membranes. The proteins are reacted with the monoclonal antibody and visualized using an HRP conjugated goat anti-mouse antibody and chemiluminescent detection.

Materials:

1. Equipment

• Electrophoresis apparatus
• Rocker platform

2. Solutions and Reagents

• Anti-DCC (Ab-1), Cat. No. OP45
• Anti-mouse IgG conjugated to horseradish peroxidase
• Chemiluminescent detection reagents
• 1x Laemmli Sample Buffer: 60 mM Tris-Cl, pH 6.8, 2% SDS, 10% glycerol, 100 mM DTT, 0.001% Bromophenol Blue
• 7.5% polyacrylamide gel
• Tris-buffered saline (TBS) pH 7.6: 20 mM Tris base, 137 mM NaCl, pH to 7.6 with HCl
• TBS/0.1% Tween®-20 detergent (TBST)
• 10% Non-fat Dry Milk in TBST
• 5% Non-fat Dry Milk in TBST

Procedure:

1) Lyse cells in 1x Laemmli Sample Buffer. For adherent cells, lyse a 10 cm plate in 2 ml of sample buffer added directly to cells on the plate. Final protein concentration is approximately 1 mg/ml.
2) Electrophorese 50-100 µg of total lysate protein on SDS/PAGE (7.5% polyacrylamide).
3) Transfer the proteins onto a nitrocellulose membrane using an electroblotting apparatus.
4) Block the membrane for 1 h in 10% non-fat dry milk in TBSTat room temperature with rocking. Use about 1 ml per cm2 of membrane.
5) Incubate the membrane with 1 µg/ml of Anti-DCC (Ab-1) in 5% non-fat dry milk in TBST for 2 h at room temperature with rocking.
6) Wash the membrane 3 times, 10 min each, in TBST at room temperature with rocking
7) Incubate the membrane with 100 ng/ml of HRP conjugated goat anti-mouse IgG antibody in 5% non-fat dry milk in TBST at room temperature for 1 h.
8) Wash the membrane 6 times, 10 min each, in TBST at room temperature with rocking.
9) Develop the membrane using chemiluminescent detection reagents according to manufacturers instructions.
10) Expose the membrane to film for 10 min. Adjust exposure times (from 30 s to 24 h) as necessary.
Storage +2°C to +8°C
Do Not Freeze Yes
Toxicity Standard Handling
ReferencesDunlop, M.G. 1992. Cancer Biol. 3, 131.
Goyette, M.C., et al. 1992. Mol. Cell. Biol. 12, 1387.
Hohne, M.W., et al. 1992. Cancer Res. 52, 2616.
Huang, Y., et al. 1992. Cancer Res. 52, 6525.
Kikuchi-Yanoshita, R., et al. 1992. Cancer Res. 52, 3801.
Tanaka, K., et al. 1991. Nature 349, 340.
Fearon, E.R., et al. 1990. Science 247, 49.
Fearon, E.R., and Vogelstein, B. 1990. Cell 61, 759.
Miyaki, M., et al. 1990. Cancer Res. 50, 7166.
Vogelstein, B., et al. 1989. Science 244, 207.